Sixfold Bioscience
Latest round
- Seed
Last raised
- Dec 2021
Total raised
- $10M
Investors
- 4
About Sixfold Bioscience
Founded in 2017 by CEO Dr. George Foot and based in London, UK, Sixfold Bioscience Ltd operates as a developer of RNA therapeutics for cell diseases. Sixfold develops programmable drug delivery systems and short interfering RNA for gene silencing and messenger RNA for gene expression. Sixfold’s Mergo platform consists of the RNA therapeutic and biocompatible building blocks that are assembled using chemistry, screened and then tested to modulate the pharmacokinetic and pharmacodynamic properties of the system and to target selected cell types. The Mergo system then learns the combination for delivery to a given tissue.
Who invested in Sixfold Bioscience
4 investors across 1 round
See all investors in Sixfold Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 2, 2021
Amount
$10M
Investors
Questions about Sixfold Bioscience
Who invested in Sixfold Bioscience?
Sixfold Bioscience has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sixfold Bioscience raised?
Sixfold Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sixfold Bioscience last raise money?
Sixfold Bioscience's most recent round on record is a Seed, in Dec 2021.
What does Sixfold Bioscience do?
Sixfold Bioscience is a biotechnology company.
Where is Sixfold Bioscience headquartered?
Sixfold Bioscience is headquartered in London, UK.
Which VCs invest in companies like Sixfold Bioscience?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Sixfold Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Sixfold Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.